Age and the treatment of multiple myeloma. Southeastern Cancer Study Group experience
- 1 September 1985
- journal article
- research article
- Published by Elsevier in The American Journal of Medicine
- Vol. 79 (3) , 316-324
- https://doi.org/10.1016/0002-9343(85)90310-9
Abstract
No abstract availableThis publication has 15 references indexed in Scilit:
- Comparison of two long-term chemotherapy regimens, with or without agents to modify skeletal repair, in multiple myelomaBlood, 1984
- Clinical trials and drug toxicity in the elderly. The experience of the eastern cooperative oncology groupCancer, 1983
- Cooperative groups and community hospitals. Measurement of impact in the community hospitalsCancer, 1983
- Effects of Age on Responses to Treatment and Survival of Patients with Multiple MyelomaJournal of the American Geriatrics Society, 1983
- Multiple myeloma in the United States, 1950–1975Cancer, 1981
- Combination chemotherapy with intermittent 1-3-bis(2-chloroethyl)1- nitrosourea (BCNU), cyclophosphamide, and prednisone for multiple myelomaBlood, 1979
- A clinical staging system for multiple myeloma correlation of measured myeloma cell mass with presenting clinical features, response to treatment, and survivalCancer, 1975
- Frequency of Pathological Proteins (M‐components) in 6,995 Sera from an Adult PopulationActa Medica Scandinavica, 1966
- A generalized Wilcoxon test for comparing arbitrarily singly-censored samplesBiometrika, 1965
- Nonparametric Estimation from Incomplete ObservationsJournal of the American Statistical Association, 1958